Alzheimer’s disease, frontotemporal dementias, progressive supranuclear palsy, Corticobasal degeneration,   Clinical Trial Study

A Phase 1b, 12-Month, Randomized, Double Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of Salsalate in Patients with Mild to Moderate Alzheimer’s Disease (UC-SAL-AD-001)

ID
NCT03277573
Condition Studied
Alzheimer's Disease
Phase
Phase I
Status
Closed
Intervention
Salsalate tablets
Sponsor
Adam Boxer, MD, PhD
Contact Coordinator

Please go to ClinicalTrials.gov for more information.